2 years of the excellent #RecoveryTrial - 4 therapies proven to work but importantly many more proven ineffective preventing unnecessary treatment.
Really proud to have been a part of it.

First patient ⁦St George's NHS FT⁩ to receive #convalescentplasma in #recoverytrial for #covid19

First patient randomised to Convalescent Plasma #Recoverytrial QEHResearch Thank you so much Tilney ward @TilneyTeamQEH The QEH King's Lynn

Congratulations to the #RECOVERYtrial on their big win of the David Sackett Trial of the Year award!

📣 Announcing Next #IDJClub

Mon Feb 15 (9 pm EST)

We’ll discuss the #Tocilizumab 💪 of the #RECOVERYtrial

Tocilizumab ⬇️ mortality (!)... but how to reconcile with other RCTs? Is it 🕰 to elevate it to standard care?

All welcome! #WeAreThePeerReview

medrxiv.org/content/10.110…

We have just wrapped up #RECOVERYmeeting2024 . It was a huge success thanks to the amazing work of the OUCRU team. Working on #RECOVERYTrial has been one of the highlights of my career!

It's amazing to see results from a study so quickly! We are extremely proud to be part of this study, and are so grateful to all our patients involved, who without, we wouldn't be able to search for new treatments! #RECOVERYTrial Oxford Population Health (OxPop)

🎬| The #RECOVERYTrial is the world's largest COVID-19 drug trial.

Thanks to the work of RECOVERY, patients hospitalised with severe #COVID19 now have two treatments that are known to improve survival.

Find out all you need to know about the trial ⬇️

#ClinicalTrialsDay

Today is the two year anniversary of the #RECOVERYtrial :

- Over 47,000 participants.

- Nearly 200 hospital sites, across six countries.

- Ten results and four effective #COVID19 treatments.

Find out more about this international effort to save lives.
➡️bit.ly/3D3JabH

We have recently recruited our 100th patient to the #RECOVERYTrial .

Our current total of 109 is a remarkable recruitment rate of 38% of eligible patients, against a national baseline target of 10%.

Brilliant work by all our staff involved in vital #COVID19 research 👏

#covidvaccinated and ready for work EMERGE #RECOVERYtrial Congrats Adult Mental Health Inpatient Services at the REH for such a smooth process! 😊🌈 #ivehadmycovidvaccine

Do monoclonal antibodies benefit hospitalised patients with Covid19?

Yes, they do— but only if patients are seronegative at baseline.

6 fewer deaths among patients allocated to #REGEN -COV.

I summarise the #recoverytrial results.

'That's why we do this work - so that patients tomorrow are treated better than the patients yesterday.'

Powerful closing words from Prof Sir Martin Landray.

#Pharmacology2021 #pharmacology #ClinicalPharmacology #ClinicalTrials #COVID19 #RECOVERYTrial

1 yr ago today UHB Research recruited our 1st patient to #recoverytrial Its been an indescribable year! Thank you to all our patients who have taken part & thank you to our University Hospitals Birmingham colleagues who have supported us throughout #ResearchVsCovid #whywedoresearch #makespace4research

One year today #RECOVERYTrial Oxford Population Health (OxPop) started recruiting patients with #COVID19 . The results have made a real difference to outcomes & saved many lives. Big ‘thank you’ to all generous participants & our fantastic research teams NHS Lothian & EMERGE

First 100 participants enrolled in #recoverytrial #indonesia #COVID19 . MMC, RSHS, UNAIR hospitals. Great spirit in the site teams, who are currently working under very challenging conditions. Peter Horby Martin Landray

NEW #COVID19 research—In patients hospitalised with COVID-19, high-titre convalescent plasma did not improve survival or other prespecified clinical outcomes. Read hubs.li/H0NqC0P0. #RECOVERY #RECOVERY trial

The NIHR-supported #RECOVERYtrial has found that a new monoclonal antibody combination can help save lives of hospitalised patients with severe COVID-19 who were unable to generate an immune response before beginning treatment nihr.ac.uk/news/recovery-…

💊Tocilizumab sí consigue reducir la mortalidad de pacientes hospitalizados por #COVID19 si se usa en el perfil de paciente adecuado y en el momento adecuado.

Este efecto se suma al de los coricoides.

#recoverytrial The Lancet

🔗 thelancet.com/action/showPdf…

Today at North Cumbria North Cumbria Integrated Care NHS Foundation Trust North Cumbria NHS Research (NCIC) we recruited our 500th patient (&501th!)to #RecoveryTrial . A huge team effort at every level across both Whitehaven and Carlisle hospitals, very proud to be a small part of it! Martin Landray Clive Graham